Sitemap
December 10, 2017 Articles
Filter by Available Specialty
- Autoimmune conditions, infections common among diffuse large B-cell lymphoma survivors
- Chronic graft-versus-host disease triples risk for morbidity, frailty among transplant survivors
- Combination therapy effective for diffuse large B-cell lymphoma
- Gilead commits $100 million to address HIV/AIDS epidemic in Southern US
- Immunosuppressive therapy leads to transfusion independence for nearly 40% of patients with myelodysplastic syndrome
- Mogamulizumab superior to vorinostat for cutaneous T-cell lymphoma
- Need for transfusions delays hospice care for patients with leukemia
- November approvals lead FDA activity in ophthalmology
- Obese patients at greater risk for infection after adolescent idiopathic scoliosis correction
- Responses with CAR T-cell therapy appear durable for non-Hodgkin lymphoma
- Study to address gap in LGBT health care outcomes
- Tisagenlecleucel induces durable responses in relapsed, refractory DLBCL
- VIDEO: Medical costs for DOD beneficiaries lower for apixaban vs. warfarin